Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04581707
Other study ID # JO-2020Kypho
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2020
Est. completion date October 2021

Study information

Verified date January 2021
Source University Hospital Tuebingen
Contact Lisanne Exner
Phone +4970712986646
Email Lisanne.Exner@med.uni-tuebingen.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to assess the performance and safety of two balloon kyphoplasty systems (Joline®), the single balloon catheter Allevo and Quattroplasty double balloon catheter Stop'n Go, using BonOs® Inject bone cement for treatment of Vertebral Compression Fractures.


Description:

Vertebral compression fracture (VCF) is a very common medical problem and describes the collapse of a vertebral body (VB) in the spine. VCF can lead to severe pain, decreased physical function, spinal deformity and in rare cases thoracic or abdominal wall deformities, that can impair pulmonary and gastrointestinal function. A VCF can occur in patients with healthy spines upon severe trauma, in patients suffering from osteoporosis or in patients with metastatic tumors. Currently available therapy for VCF includes medical management, surgical treatments and vertebral augmentation (VA). Medical management consists of bed rest followed by early mobilization and analgesic medications. Surgical options include spinal stabilization with rods and screws. VA procedures attempt to stabilize the spine and reduce vertical compression by adding material to the spine. Kyphoplasty is a commonly performed VA procedure. In kyphoplasty, a surgical instrument is used to reduce the collapsed VB towards its original shape. Reduction of the fractured VB is thought to be beneficial since (1) it may reduce anterior directed compressive forces resulting from kyphosis of the spine due to the fracture, and (2) it may reduce some physiologic abnormalities due to kyphosis, such as restrictive lung disease or abdominal compression. After fracture reduction, bone cement is placed in the VB to stabilize the reduction. Fracture reduction follows the orthopedic general principles of fracture repair: reduction and stabilization. Primary objective of this observational study is to compare the effectiveness of the Quattroplasty double balloon catheter Stop'n GO (Joline®) with the Kyphoplasty single balloon catheter Allevo (Joline®) combined with BonOs® Inject bone cement for use in VCF reduction, to confirm the performance of those two devices and to investigate potential major adverse events associated with the use of the device in patients treated in a controlled setting when used according to the IFU. Secondary objective is to compare the safety of the Quattroplasty double balloon catheter Stop'n GO (Joline®) with the Kyphoplasty single balloon catheter Allevo (Joline®) combined with BonOs® Inject bone cement.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date October 2021
Est. primary completion date June 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients aged =18 years - 1-3 painful VCF(s), of which at least 1 meets the following criteria: - VCF between T7 and L5 - Fracture age <3 months - VCF shows hyperintense signal on STIR or T2 sequence MRI. - Investigator estimates that target VB(s) is/ are suitable for Quattroplasty double balloon catheter or Kyphoplasty single balloon catheter (e.g. appropriate pedicle diameter, no cortical bone protruding into the spinal canal). - Patient has an ODI score of 30% or more. - Patient is willing and able to comply with study requirements. - Patient signs informed consent form. - Women who are post-menopausal, surgically sterile or on contraceptives and agree to remain on contraceptives for the duration of their study participation and agree not to become pregnant during the study. Exclusion Criteria: - Segmental kyphosis of target VB of >30° - Pre-existing or clinically unstable neurologic deficit - Any physical exam evidence of myelopathy or radiculopathy - Not able to walk without assistance prior to fractures - Any radiographic evidence of pedicle fracture or interspinous-process widening - Spondylolisthesis >grade 1 at target VB(s) - History of spine surgery, including prior vertebral augmentation, during the last year - Any underlying systemic bone disease other than osteoporosis (e.g. osteomalacia, osteogenesis imperfect, etc.) - Irreversible coagulopathy and/or taking peri-operatively warfarin (Coumadin) or other anticoagulant - Pregnancy and nursing - Pain due to any other condition that requires daily narcotic medication - Disabling back pain due to causes other than acute fracture - History of intolerance, or allergic reaction to titanium or acrylic compounds - Active systemic or local infection at baseline - Severe cardiopulmonary disease (e.g. stage IV heart failure, severe chronic obstructive pulmonary disease) - Any other medical illness or condition that, in the investigator's opinion, is likely to impair long-term follow-up (e.g. cancer) or greatly increase the risk of surgery - Any evidence of substance abuse - The patient is on long-term steroid therapy (steroid dose 30 mg/day for >3 months) - The patient is known to be involved in medical litigation including Workmen's compensation. - Patient with contraindication for MRI including but not limited to patients with contraindications for general anesthesia (surgeon expertise) - Patient who is contraindicated for the use of PMMA cement - Patients who belong to a vulnerable population or that are not able to sign the informed consent form. - Patients where the VCF was treated in combination with fusion. - Patients with any contraindication according to the IFU

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Kyphoplasty Single Balloon Catheter Allevo
Vertebral compression fractures treated with Kyphoplasty Single Balloon Catheter Allevo (Joline®) and BonOs® Inject bone cement
Quattroplasty Double Balloon Catheter Stop'n GO
Vertebral compression fractures treated with Stop'n GO double balloon kyphoplasty system (Joline®) and BonOs® Inject bone cement

Locations

Country Name City State
Germany University Hospital for Orthopedics Tuebingen Tuebingen

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Tuebingen

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in vertebral body height Change in vertebral body height pre-operative, 5 days and 3 months post-operatively
Primary Change in Visual Analog Scale (VAS) of subjective pain The Visual Analog Scale (VAS) is a measure for pain intensity. The score of the sclae ranges from 0 for "no pain" to 10 for "worst imaginable pain". Patients will report their pain at baseline and at 2 dedicated periods to assess change in pain intensity. pre-operation, 5 days and 3 months post-operation
Primary Change in functional disability The Oswestry Disability Index (ODI) is used to assess functional disability. The questionnaire consists of 10 items with each item having 6 statements. All scores are summed, then multiplied by two to obtain the index (range from 0 to 100) with higher score indicating greater disability. pre-operation, 5 days and 3 months post-operation
Secondary Safety Outcomes: Occurence of adverse events and complications Occurence of adverse events and complications during procedure, 5 days and 3 months post-operation
See also
  Status Clinical Trial Phase
Completed NCT01643395 - VertebrOpLasty Versus Conservative Treatment in Acute Non Osteoporotic Vertebral Fractures Phase 3
Enrolling by invitation NCT05018637 - Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture Phase 2
Completed NCT03523000 - Determining the Prognostic Value of Continuous Intrathecal Infusion Phase 4
Recruiting NCT04835428 - STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures N/A
Recruiting NCT04821739 - RISE - Study of the AGN1 LOEP SV Kit in Patients With Vertebral Compression Fractures N/A
Completed NCT04135755 - The Spine Kinematics and Center of Pressure Excursion During Functional Task Vertebral Compression Fractures Subjects
Recruiting NCT05676320 - Investigating Bone Cement With or Without Inossia™ Cement Softener for Vertebral Compression Fractures N/A
Completed NCT01383616 - Unipedicular vs. Bipedicular Kyphoplasty for the Treatment of Osteoporotic Vertebral Fractures Phase 4
Recruiting NCT05912504 - Long Term Follow-up of Vertebral Compression Fracture In-patients Treated: A Retrospective Chart Review and Survey
Completed NCT06153576 - The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures
Completed NCT03580434 - The Purpose of This Study is to Evaluate Safety and Performance of the V-STRUT© Transpedicular Vertebral System N/A
Suspended NCT03651804 - Radiofrequency Ablation: Treatment for Posterior Element Pain From Vertebral Compression Fractures Phase 4